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bral events such as stroke are rare, between 2% and 6%
of patients have some form of neurologic injury in the
initial perioperative period. In addition, subtle neu-
ropsychologic changes develop in 20% to 60%.4,5
These changes in cognitive function may persist with an
incidence of 25% to 30% 8 weeks after the operation,
with only slightly lower levels at 1 year.6 The mecha-
nisms of these deleterious effects of CPB on the central
nervous system are multifactorial. These include
hypoperfusion during CPB,7 microemboli of a gaseous
or particulate origin,8 or inflammatory changes that
effect an increase in permeability across the blood-brain
barrier with resultant cerebral edema.9,10
A number of biochemical markers have been suggest-
ed in an attempt to quantify the neuronal injury at the
time of insult, among them protein S-100. This is an
acidic, calcium-binding protein found in high concen-
trations in glial and Schwann cells.11 The appearance of
C oronary artery bypass grafting (CABG) with car-diopulmonary bypass (CPB) is a safe, routine pro-
cedure with a mortality of 2% to 3% in elective cases.1
Nevertheless, it is still associated with significant mor-
bidity, mostly because of the cytokine response to the
nonphysiologic nature of CPB.2,3 Although gross cere-
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this protein in serum indicates both neuronal damage
and increased permeability of the blood-brain barrier.
Recently, interest in coronary revascularization on
the beating heart has been revived, with the suggestion
that avoidance of CPB may reduce neuropsychologic
damage. There are, however, no data available as part
of a prospective randomized trial on the possible rela-
tion between a recognized marker of ischemic brain
injury such as protein S-100 and neuropsychologic out-
come in patients undergoing elective CABG with or
without CPB.
Methods
Patient selection. With approval from the local research
ethical committee, 60 patients undergoing first-time CABG
were enrolled in the study. They were part of a larger prospec-
tive randomized study comparing on-pump and off-pump
surgery. From July 1997 to July 1998, 246 patients underwent
first-time CABG under the supervision of a single consultant
(G.D.A.). During this period 127 patients were eligible for
randomization. Two patients refused to consent on personal
grounds. Of the 125 remaining patients, 62 were randomized
to on-pump and 63 to off-pump surgery. Thirty patients from
each group were suitable for neuropsychologic studies. All
patients were fully informed and signed consent forms.
Exclusion criteria included cardiac ejection fraction of less
than 30%, myocardial infarction within the previous 1 month,
disease involving the distal circumflex coronary artery, reop-
eration or combined valvular surgery, respiratory or renal
impairment, and coagulopathy. Meticulous care was taken to
exclude patients with previous psychiatric illness, previous
stroke, or transient ischemic attacks, and any patient with sus-
pected carotid artery disease underwent carotid duplex ultra-
sonography. The enrolled patients were prospectively ran-
domized into 2 groups by card allocation: (1) on-pump
group—conventional myocardial revascularization with CPB
and cardioplegic arrest of the heart; (2) off-pump group—
revascularization on the beating heart.
Anesthetic technique. Anesthetic technique was standard-
ized for all patients. This consisted of propofol infusion at 3
mg · kg–1 · h–1 combined with remifentanil infusion at 0.5 to
1 µg · kg–1 · min–1. Neuromuscular blockade was achieved
with 0.1 to 0.15 mg · kg–1 of pancuronium or vecuronium and
the lungs were ventilated to normocapnia with 45% to 50%
oxygen in nitrogen. Propofol and remifentanil infusions were
maintained throughout the operation. In the on-pump group,
metaraminol or phentolamine was used as required to main-
tain the systemic pressure between 50 and 60 mm Hg. In the
off-pump group, a mean arterial pressure of 60 mm Hg or
above was maintained with metaraminol or fluids as indicat-
ed by the hemodynamic condition. Esmolol was used as nec-
essary to maintain the heart rate less than 65 beats/min.
Heparin and protamine management. In the on-pump
group, heparin was given at a dose of 300 IU · kg–1 to achieve
a target activated clotting time (ACT) of 480 seconds or
above before the start of CPB. In the off-pump group, a
heparin dose of 100 IU · kg–1 was given before the start of the
first anastomosis. The target ACT in this group was between
250 and 350 seconds. Protamine was used at the end to
reverse the effect of heparin and return the ACT to preopera-
tive levels.
Surgical technique 
On-pump group. CPB was instituted by means of ascend-
ing aortic cannulation and a 2-stage venous cannulation via
the right atrium. A standard CPB circuit was used consisting
of a Bard tubing set (C. R. Bard, Inc, Santa Ana, Calif), which
included a 40-µm filter, a Stöckert roller pump (Sorin
Biomedica, Midhurst, United Kingdom), and a hollow-fiber
membrane oxygenator (Monolyth, Sorin Biomedica,
Midhurst, United Kingdom). The extracorporeal circuit was
primed with 1000 mL of Hartmann solution, 500 mL of gelo-
fusine, a 0.5 g · kg–1 concentration of mannitol, 7 mL of 10%
calcium gluconate, and 60 mg of heparin. Nonpulsatile flow
was used. The flow rate throughout bypass was 2.4 L · m2 ·
min–1. Systemic temperature was allowed to vary between
32˚C and 34˚C. Myocardial protection was achieved by
means of intermittent antegrade warm blood cardioplegia as
described by Calafiore and associates.12
Once all distal anastomoses had been completed, the aortic
crossclamp was removed and the proximal anastomosis was
carried out with partial clamping of the aorta.
Off-pump group. The method of exposure and stabilization
used to carry out the distal anastomoses was a combination of
the technique previously described by our group13 and the use
of the CTS retractor (CardioThoracic Systems, Cupertino,
Calif).14 The target vessel was exposed and snared above the
chosen point for anastomosis by means of a 4-0 Prolene
polypropylene suture (Ethicon, Inc, Somerville, NJ) with a
soft piece of plastic “snugger” to prevent coronary injury. The
coronary artery was then opened and the anastomosis per-
formed with a continuous suture. Visualization was enhanced
by a surgical blower-humidifier device (model SSVW-002;
Surgical Site Visualization Wand; Research Medical Inc,
Midvale, Utah) with a 1⁄4-inch polyvinyl chloride gas line and
fluid administration set connected to a regulated gas source of
medical air. An intracoronary shunt (Anastoflo Intravascular
Shunt; Research Medical Inc) was used only if there was
appreciable electrocardiographic or hemodynamic instability
or excessive bleeding during the construction of the anasto-
mosis.
Samples for serum S-100 protein analysis. Blood sam-
ples (4 mL) were collected from the central venous pressure
line at induction of anesthesia, 30 minutes after cessation of
CPB in the on-pump group or 30 minutes after completion of
all anastomoses in the off-pump group, and 4, 12, and 24
hours after the operation. The samples were centrifuged with-
in an hour of collection to separate the serum, which was
frozen and stored at –20˚C.
S-100 protein assay. The S-100 immunoradiometric assay
(Sangtec 100; Sangtec Medical AB, Bromma, Sweden) is a
monoclonal 2-site immunoradiometric (sandwich) assay. The
method discriminates between the α-subunit and β-subunit
150 Lloyd et al The Journal of Thoracic and
Cardiovascular Surgery
January 2000
(β-S-100 is present in high concentration in glial cells and
Schwann cells) and measures the β-subunit of the S-100 protein
as defined by the 3 monoclonal antibodies SMST 12, SMSK
25, and SMSK 28. All samples were independently analyzed by
Cambridge Life Sciences, Cambridge, United Kingdom.
Clinical and neuropsychologic assessment. The preoper-
ative assessment included all of the usual clinical and inves-
tigation measures. The general level of risk for cardiac oper-
ations was expressed in terms of the New York Heart
Association classification and Parsonnet’s operative risk
stratification.15 Postoperative neurologic status was assessed
daily by clinical examination until the patient was discharged
from the hospital. The patient’s neurologic and neuropsycho-
logic state was assessed a few days before the operation, to
provide accurate baseline information, and 12 weeks after the
operation. A suitably qualified and trained examiner, blinded
to the surgical treatment, carried out the tests in a standard-
ized manner. In accordance with the “Statement of Consensus
on Assessment of Neurobehavioral Outcomes After Cardiac
Surgery,”16 we subjected the patients to a battery of core tests
that covered memory, language, psychomotor speed, atten-
tion, and concentration. This consisted initially of 2 tests
from the Wechsler Memory Scale (WMS) and a battery of 5
neuropsychologic tests taken from the revised Wechsler
Adult Intelligence Scale (WAIS).17 These are accepted tests
of global cognitive function. The tests were presented in a
fixed order according to conventional practice, and the scores
were arranged such that larger scores indicated better neu-
ropsychologic performance.
In addition, because cognitive function may be influenced
by mood,16 each patient’s current mental health was assessed
by means of the General Health Questionnaire (GHQ-30)18
and Hospital Anxiety and Depression Scale (HAD).19
Statistical methods. As in our group’s work in this area,17
the principal outcome measure of change in cognitive func-
tion for each patient was the number of neuropsychologic
tests showing deterioration between baseline and the assess-
ment 12 weeks after the operation. The numbers recruited
were based on the requirement for 90% power to detect a dif-
ference of 1.18 scores, with an alpha error set at 0.05. This
was the same difference that we saw in our previous study17
between patients who received CPB perfusion at 32˚C and
those who received it at 37˚C. The difference in this measure
between on-pump and off-pump groups was examined in a sin-
gle variable model by means of the Student t test and in a
multivariable model to examine for the effects of any docu-
mented confounders. A stepwise multiple regression was
undertaken, offering age, the changes in scores for Hospital
Anxiety and Hospital Depression in the General Health
Questionnaire, and the treatment (on pump or off pump) as
explanators. This analysis, which examined only the direction
of change without taking into account the magnitude, was
supported by a multivariate analysis of variance (MANOVA),
using a general linear model and offering age and the scores
for Hospital Anxiety and Hospital Depression as possible
confounders.
For effects on S-100 protein over time, the prospectively
planned analysis was a repeated-measures analysis of vari-
ance (ANOVA), applied to the data from the 4 collection
times after the preoperative sample. This was to examine for
effects of time, group, and group-time interaction. When the
data were obtained, the concentration values at most of the
measurement times were not normally distributed, so that
the probability estimates from the ANOVA were potentially
unreliable. For supporting analyses, the area under the con-
centration curve (AUC) from the second sample time was cal-
culated by triangulation as a summary measure for each
patient. This measure was not normally distributed. A Mann-
Whitney U test was used to examine whether this measure
varied between groups (on pump or off pump). Subsidiary
Mann-Whitney testing was also undertaken on the concentra-
tions at each sampling time. A Kruskal-Wallis test was used
to examine for variation with the primary outcome variable
(number of deteriorations in neuropsychologic scores) and a
Spearman rank correlation to examine for variation with age.
All descriptive statistics and inferential testing were carried
out by means of procedures in StatView (SAS Institute, Inc,
Cary, NC) or Minitab 10.1 for Windows (Minitab Inc, State
College, Pa).
Results
Table I indicates the distributions of age, sex, extent of
disease, left ventricular function, and number of grafts of
the patients in each group. In the inferential testing that
was undertaken to check on the effectiveness of the ran-
domization, the only notable result was that the observed
difference in age between the 2 groups was to be expect-
ed in only 5.4% of random allocations of this sort. None
Table I. Preoperative clinical data
On-pump Off-pump 
group group 
Variable (n = 30) (n = 30) P value
Male 27 26 .7
Female 3 4 .7
Age (y) 62 (56-69) 59 (54-64) .1
Diabetes 4 3 .1
Extent of disease .9
One-vessel disease 5 6
Two-vessel disease 13 13
Three-vessel disease 12 11
Angina class .9
Grade I 3 2
Grade II 17 16
Grade III 6 8
Grade IV 4 4
Ejection fraction .2
Good (>50%) 25 28
Moderate (30%-50%) 5 2
Parsonnet score 4 (2-7) 4 (0-6) .2
Data are presented as medians with interquartile ranges.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 119, Number 1
Lloyd et al 151
of the patients who were referred for duplex carotid
ultrasonography had a carotid stenosis greater than 50%.
There were no deaths, major neurologic complications,
or intraoperative myocardial infarctions in either group.
Intubation time, intensive care stay, and length of hospi-
tal stay were significantly shorter in the off-pump group
than in the on-pump group (Table II).
Numbers of deteriorations in neuropsychologic
tests. Fig 1 shows the distributions of numbers of dete-
riorations in each group. The average number in the
off-pump group was 2.13 (95% confidence interval
[CI] on mean 2.58-1.67) and 2.19 (95% CI on mean
2.65-1.735) in the on-pump group (P = .9). The step-
wise multiple regression identified only the change in
the depression component of the HAD score as a sig-
nificant (P < .03) explanator. The standard deviation of
the regression coefficient was 0.05. The regression
explained only 7% of the variance of the primary out-
come variable (coefficient of determination 0.07). The
distributions for the GHQ and HAD scores are shown
in Table III. The average preoperative and postopera-
tive scores were similar for the 2 groups.
The MANOVA carried out on the 7 neuropsycholog-
ic scores confirmed the result indicated by the primary
outcome variable in that there was no significant dif-
ferent difference between on-pump and off-pump
groups in the magnitude of change across all 7 dimen-
sions of outcome (P = .18).
S-100 protein concentration. Fig 2 shows the distri-
butions of S-100 protein concentrations in the 2 groups
at the different sampling times, with “box and whisker”
Table II. Operative and postoperative data
On-pump Off-pump 
group group 
Variable (n = 30) (n = 30) P value
CPB time (min) 72.9 ± 28.3
Crossclamp time (min) 47.3 ± 18.7
Graft/patient (n) 2.4 ± 0.9 2.2 ± 0.9 .5
Graft distribution .1
LAD graft (n) 30 30
Diag. graft (n) 7 8
RCA/PDA graft (n) 15 16
Cx territory graft (n) 20 13
Stroke 0 0 1.0
TIA 0 0 1.0
Intubation time (h) 11.2 ± 7.5 6.0 ± 2 .01*
ITU length of stay (d) 1.3 ± 0.6 1.0 ± 0.2 .01*
Postop. length of stay 7.1 ± 2.2 5.8 ± 1.5 .01*
(d)
Data are presented as mean ± standard deviation. TIA, Transient ischemic
attack; LAD, left anterior descending coronary artery; Diag, diagonal branch
of LAD; RCA, right coronary artery; PDA, posterior descending artery; Cx,
circumflex artery.
*Statistical significance.
Fig 1. Deteriorations in neuropsychologic test score in the
on-pump and off-pump groups.
Fig 2. Serum S-100 protein levels (micrograms per liter) up
to 24 hours after the operation in the on-pump and off-pump
groups. Data are presented as medians with interquartile and
total ranges.
Table III. Scores in General Health Questionnaire
(GHQ) and Hospital Anxiety and Depression (HAD)
GHQ HAD anxiety HAD depression
On-pump group
Preop. 27 (18-33) 4 (2-7) 3 (1-6)
12 wk 17 (14-28) 2 (1-3) 1 (0-4)
Off-pump group
Preop. 27 (21-34) 6 (3-9) 4 (2-5)
12 wk 19 (13-27) 4 (2-5) 2 (1-3)
Data are presented as medians with interquartile ranges.
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symbols used to indicate medians, interquartile ranges,
and total ranges. The prospectively planned repeated-
measures ANOVA identified a highly significant (P =
.02) effect of group (on pump or off pump) and a very
highly significant effect of time (P = .01) and group
time interaction (P = .02) (ie, the difference between
groups depended on the sampling time). Testing at
individual sampling times with Bonferroni correction
showed a highly significant difference (P = .01) at the
30-minute sampling time but not at subsequent sam-
pling periods. The reliability of the P values is called
into question by the skewedness of the data, as indicat-
ed in Fig 2. Analysis of residuals showed significant
non-normality in their distribution about the ANOVA
model, and this could not be usefully reduced by a sim-
ple logarithmic transformation. The suspect findings of
the repeated-measures ANOVA were supported by the
difference in AUC of the S-100 protein concentrations
between the 2 treatment groups. The median AUC in
the on-pump group was 3.14 µg · h–1 · L–1 with an
interquartile range from 1.89 to 6.90, whereas in the
off-pump group it was 2.19 with an interquartile range
from 0.80 to 3.52 (Mann-Whitney test, P = .6). The
Bonferroni-corrected Mann-Whitney tests on the con-
centrations at each sampling time indicated that any
difference in AUC was largely due to the difference in
concentration at 30 minutes. Table IV shows the medi-
an AUCs and interquartile ranges in the groups charac-
terized by number of neuropsychologic deteriorations.
There was no obvious trend (Kruskal-Wallis test, P =
.2). The very large AUC in 1 of the 3 patients with 5
score deteriorations was in a patient whose baseline S-
100 concentrations were already high. The Spearman
rank correlation for AUC with age was 0.507 (P = .05).
Conclusions
Fundamental changes in the demographics of the car-
diac surgical population have been observed over the
past decade, mostly among patients undergoing CABG
operations. Largely as a result of factors related to the
increasing age of this group, major neurologic compli-
cations now constitute a growing percentage of serious
postoperative morbidity.20-23 Furthermore, minor neu-
rologic and neuropsychologic complications are report-
ed to occur in up to 60% of patients in the first week
after a cardiac operation and persist in one third of
patients 6 months later. Given these adverse sequelae of
CPB in terms of not only cerebral but also myocardial,
renal, respiratory, and coagulation impairment, a
revival of interest in performing CABG on the beating
heart began in the early 1990s.24-27 This technique has
now faced and resolved most of the concerns regarding
cardiac motion, anastomotic site exposure, number of
grafts, and anastomosis quality.13,14 Recently, in a
prospective randomized study,28 we showed preserva-
tion of myocardial function in off-pump compared with
on-pump patients with less postoperative morbidity.
Our study certainly found no major postoperative neu-
rologic complications in either the on-pump or off-
pump group. However, there are inherent difficulties
with the detection of functional subclinical problems
such as cognitive dysfunction. A vast array of neu-
ropsychologic tests exists to try to quantify these prob-
lems. We carried out our neuropsychologic assessment
according to the “Statement of Consensus on Assess-
ment of Neurobehavioral Outcomes After Cardiac
Surgery.”16 We chose our outcome measure as the num-
ber of deteriorations in our bank of 7 neuropsycholog-
ic tests for the same reason that we chose it in our
group’s study17 of the effect of CPB temperature on
cognitive performance. It was bound to be more sensi-
tive than any of the existing binary measures based on
the occurrence or not of “neuropsychologic deficit,”
defined in terms of whether or not a variously specified
number of tests had deteriorated by a variously speci-
fied amount. Our present study showed no significant
difference between the 2 groups in this measure of neu-
ropsychologic outcome 12 weeks after the operation.
The study achieved 90% power to detect a deterioration
of the same size (1.18 scores) as we observed in our
previous study17 between CPB perfusion at 32˚C and
37˚C (the clinical importance of which we could not
determine).
Currently, serum S-100 protein is widely recognized
as the most accurate biochemical marker of neuronal
injury.5,8,11 The most conservative, nonparametric
analysis of the serum S-100 protein concentrations
over time gave only 94% confidence that there was a
bigger rise in the on-pump group. Even the apparently
more discriminating but also more suspect repeated-
Table IV. Neuropsychologic deteriorations and area
under the curve (AUC) of S-100 protein concentra-
tions over time
Interquartile 
No. of No. of Median AUC ranges 
deteriorations patients (µg · h–1 · L–1) of AUC
0 5 1.236 0.000-4.200
1 14 2.807 1.045-3.889
2 19 3.302 0.672-7.242
3 15 2.226 1.156-3.234
4 5 1.900 0.950-8.040
5 3 3.588 3.500-23.07
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measures ANOVA indicated that any such difference
had been measured only at 30 minutes after the opera-
tion and had essentially disappeared by 4 hours. Even
if the existence of a short-lasting difference in S-100
protein concentrations between the on-pump and off-
pump groups is accepted, it is not necessarily attribut-
able to the presence or absence of the pump. The ran-
domization happened to produce a slight
preponderance of relatively older patients in the on-
pump group, and the AUC of the S-100 protein con-
centrations tended to increase with increasing age.
Both the association with age and the rapid disappear-
ance of elevated postperfusion concentrations of S-100
protein are in accordance with observations by other
authors.5,11,29 Westaby and associates5 speculated that
the elevations reflect diffuse microembolic cerebral
injury together with increased permeability of the
blood-brain barrier rather than irreversible cerebral
damage through neuronal ischemia. Their studies show
a correlation of S-100 protein not only with the dura-
tion of CPB but also with the presence of carotid artery
stenoses.8 The clearance of S-100 protein is reduced by
reduction in glomerular filtration rate. This may be a
plausible explanation for the transient rise in S-100
protein in the on-pump group, but further studies would
need to confirm this. Our results may support the
hypothesis that, at least in carefully selected, relatively
young patients undergoing elective operations, with no
previous history of neurologic injury, modern CPB
causes only a transient loss of cerebral autoregulation
with increased permeability of the blood-brain barrier
resulting in temporary, functional rather than long-
term, structural changes. It remains to be seen whether
this is so in more elderly patients with pre-existing neu-
rologic deficits.
We thank Amanda Burston for her invaluable help with the
neuropsychologic testing and Simon Howell for his help in
preparing this manuscript.
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